Metoprolol tartrate and Hydrocele - a phase IV clinical study of FDA data

Summary:

Hydrocele is reported as a side effect among people who take Metoprolol tartrate (metoprolol tartrate), especially for people who are 60+ old, have been taking the drug for 1 - 6 months also take Zometa, and have Multiple myeloma.

The phase IV clinical study analyzes which people have Hydrocele when taking Metoprolol tartrate. It is created by eHealthMe based on reports of 83,460 people who have side effects when taking Metoprolol tartrate from the FDA, and is updated regularly.

What is Metoprolol tartrate?

Metoprolol tartrate has active ingredients of metoprolol tartrate. It is often used in high blood pressure. eHealthMe is studying from 89,747 Metoprolol tartrate users. Check the latest studies of Metoprolol tartrate.

What is Hydrocele?

Hydrocele is found to be associated with 275 drugs and 388 conditions by eHealthMe. Check the latest studies of Hydrocele.

On Jul, 26, 2026

83,460 people reported to have side effects when taking Metoprolol tartrate.
Among them, 47 people (0.06%) have Hydrocele.

Could Metoprolol tartrate cause Hydrocele?

Among these 47 people:

How long have people been on Metoprolol tartrate when they have Hydrocele? *

What is the age of people who have Hydrocele when taking Metoprolol tartrate? *

What are other drugs people take besides Metoprolol tartrate? *

Zometa: 32 people, 68.09%
Lasix: 26 people, 55.32%
Aredia: 26 people, 55.32%
Lorazepam: 25 people, 53.19%
Prednisone: 25 people, 53.19%
Prilosec: 24 people, 51.06%
Chlorhexidine Gluconate: 24 people, 51.06%
Simvastatin: 24 people, 51.06%
Percocet: 23 people, 48.94%
Coumadin: 22 people, 46.81%

What are other side effects people have besides Hydrocele? *

Stress And Anxiety: 35 people, 74.47%
Pain: 34 people, 72.34%
Osteonecrosis Of Jaw (death of bone of jaw): 32 people, 68.09%
Insomnia (sleeplessness): 31 people, 65.96%
Joint Pain: 31 people, 65.96%
Anaemia (lack of blood): 29 people, 61.70%
Acute Kidney Failure: 28 people, 59.57%
Diarrhea: 27 people, 57.45%
Hypoaesthesia (reduced sense of touch or sensation): 27 people, 57.45%
General Physical Health Deterioration (weak health status): 27 people, 57.45%

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 31 people, 65.96%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 7 people, 14.89%
Depression: 6 people, 12.77%
Stable Angina (a constant chest pain): 5 people, 10.64%
Metastases To Bone (cancer spreads to bone): 5 people, 10.64%
Pain: 4 people, 8.51%
Hypersensitivity: 3 people, 6.38%
High Blood Cholesterol: 2 people, 4.26%
Hyperchlorhydria (gastric acid levels are higher in stomach): 2 people, 4.26%
Immunodeficiency Disorders: 2 people, 4.26%

* Approximation only. Some reports may have incomplete information.

Do you take Metoprolol tartrate and have Hydrocele?

- Check whether Hydrocele is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Metoprolol tartrate:

Metoprolol tartrate (89,747 reports)

Hydrocele treatments and more:

Hydrocele (1,718 reports)

Browse all side effects of Metoprolol tartrate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hydrocele:

Hydrocele (275 drugs)

Browse all the conditions that are associated with Hydrocele:

Hydrocele (388 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on metoprolol tartrate (the active ingredients of Metoprolol tartrate) and Metoprolol tartrate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.